Aethlon Medical shareholders approve equity plan amendments and board elections

Aethlon Medical, Inc., a company listed on the NASDAQ under the ticker AEMD, recently concluded its annual stockholder meeting in a virtual format. The meeting saw the election of five new directors, including Edward G. Broenniman, James B. Frakes, Nicolas Gikakis, Angela Rossetti, and Chetan S. Shah, MD, who will serve until the next annual meeting.

Shareholders also approved amendments to the company’s equity incentive plan, changes to the corporate charter, and the issuance of up to 1,126,602 shares of common stock related to warrants. Additionally, the company’s independent registered public accounting firm, Haskell & White LLP, was ratified to serve until March 31, 2027.

The meeting also included approval for compensation of named executive officers and an amendment to the 2020 Equity Incentive Plan to increase the number of shares authorized for issuance. These decisions were made with the majority of votes cast in favor, except for a few proposed changes that received votes against.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.